EUCTR2009-014571-49-IT进行中（未招募）不适用
The use of systemic propranolol in congenital hemangiomas - CDO0901
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点开始时间: 2010年1月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients > 4 weeks of age and < 12 months of age, with one of the following features: - Large congenital hemangioma - Hemangioma in a critical site - Both the conditions above mentioned - Patients whose parents have signed a informed consent
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Hypersensitivity to propranolol in first degree relatives - Severe clinical conditions that contraindicate the inclusion in the study - Mellitus diabetes
研究者
相似试验
已完成
2 期
Propranolol in treatment of hemangiomaHemangioma.Hemangioma, any siteIRCT2014041817325N1Ardabil University of Medical Sciences20
已完成
不适用
Propranolol therapy for pediatric hemangioma and lymphangiomapediatric hemangioma and lymphangiomaJPRN-UMIN000005990Tohoku University Hospital
已完成
不适用
Propranolol for infantile hemangiomasInfantile hemangiomasJPRN-UMIN000011944Plastic and Reconstructive Surgery, Keio university, School of medicine30
已完成
不适用
Oral propranolol therapy for infantile hemangiomasInfantile hemangiomasJPRN-UMIN000007664Tokushima University Hospital30
已完成
2 期
Effect of oral propranolol on benign vascular tumors in children under 15 yearsCutaneous hemangioma.D18.1?D18.0IRCT2015011920715N1Arak University Of Medical Science32